Skip to main content
Premium Trial:

Request an Annual Quote

Toronto's Mt. Sinai to Use Xceed Molecular's Gene Expression System

NEW YORK (GenomeWeb News) – The reference laboratory at Toronto’s Mt. Sinai Hospital will use Xceed Molecular’s gene expression analysis systems to provide services to North American translational research customers and for use in the hospital’s own programs, the company said today.
 
The Mt. Sinai’s Services unit, which is CLIA-certified by the Ontario Laboratory Accreditation Program, has acquired the company’s Ziplex System.
 
Xceed’s CEO, David Deems, said the partnership allows the company to expand service offerings in North America and to validate its new Xpress Chips — preconfigured arrays that are being developed “for a wide range of disorders.”
 
Financial terms of the agreement were not released.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.